Immunomodulation of T(H)2 biased immunity with mucosal administration of nanoemulsion adjuvant

T(H)2-biased immune responses are associated with inadequate protection against some pathogens and with cancer, colitis, asthma and allergy. Since most currently used vaccine adjuvants induce a T(H)2-biased response, this has led to interest in developing adjuvants capable of activating T(H)1 immuni...

Descripción completa

Detalles Bibliográficos
Autores principales: Bielinska, Anna U., O’Konek, Jessica J., Janczak, Katarzyna W., Baker, James R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962973/
https://www.ncbi.nlm.nih.gov/pubmed/27317451
http://dx.doi.org/10.1016/j.vaccine.2016.06.043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962973/
https://www.ncbi.nlm.nih.gov/pubmed/27317451
http://dx.doi.org/10.1016/j.vaccine.2016.06.043

Ejemplares similares